SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-022919
Filing Date
2022-11-08
Accepted
2022-11-08 08:01:00
Documents
13
Period of Report
2022-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pmvp-20221108.htm   iXBRL 8-K 69040
2 EX-99.1 pmvp-ex99_1.htm EX-99.1 282815
  Complete submission text file 0000950170-22-022919.txt   487178

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pmvp-20221108_pre.xml EX-101.PRE 11056
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pmvp-20221108_lab.xml EX-101.LAB 17769
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pmvp-20221108.xsd EX-101.SCH 2465
7 EXTRACTED XBRL INSTANCE DOCUMENT pmvp-20221108_htm.xml XML 4705
Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39539 | Film No.: 221367313
SIC: 2834 Pharmaceutical Preparations